The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin

Aim. To study the effect of rivaroxaban compared with warfarin on the incidence of cardioembolic stroke and systemic thromboembolic complications (TEC), bleeding in patients with non-valvular atrial fibrillation (AF).Material and methods. Patients (n=126) older than 18 years, appealed to the Cardiol...

Full description

Bibliographic Details

Published in:	Рациональная фармакотерапия в кардиологии
Main Authors:	I. Yu. Koroleva, I. V. Kolesnichenko, V. P. Nosov, M. V. Zlobin, D. I. Abelevich
Format:	Article
Language:	English
Published:	Столичная издательская компания 2016-11-01
Subjects:	atrial fibrillation rivaroxaban warfarin
Online Access:	https://www.rpcardio.online/jour/article/view/1336